Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.34
+0.09 (1.71%)
Aug 27, 2026, 1:56 PM HKT

HKG:2566 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2981,3061,3691,2871,1251,307
Revenue Growth
-0.60%-4.59%6.35%14.39%-13.91%-
Gross Profit
1,0411,0541,082990.67854.26950.41
Operating Income
151.69141.3157.05137.4245.91130.28
Net Income
139.5138.41138.6119.7859.87119.41
Earnings Per Share
0.570.560.680.600.300.60
EPS Growth
1.46%-16.89%13.32%100.07%-49.87%-

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Mainland China
1,2631,2611,3161,2461,0741,171
Other Countries/Regions
35.9645.4753.341.9151.8136.57
Total
1,2981,3061,3691,2871,1251,307

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
661.72714.47611.38126.14115.98127.8
Total Debt
189.68161.62120.72167.07220.58204
Net Cash (Debt)
472.04552.85490.66-40.93-104.6-76.2
Net Cash Growth
-14.62%12.67%----
Net Cash Per Share
1.942.252.40-0.20-0.52-0.38

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-254.8494.79135.7722.5667.53
Capital Expenditures
--49.59-15.09-21.1-23.3-53.94
Free Cash Flow
-205.2579.69114.66-0.7413.59
Free Cash Flow Growth
-157.56%-30.50%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
80.15%80.69%79.00%76.95%75.91%72.70%
Operating Margin
11.68%10.82%11.47%10.67%4.08%9.97%
Pretax Margin
12.43%12.36%12.32%10.48%4.57%9.76%
Profit Margin
10.74%10.60%10.12%9.30%5.32%9.13%
FCF Margin
-15.71%5.82%8.91%-0.07%1.04%

Dividends

Fiscal YearCurrentFY 2025FY 2024
Period EndingAug '26 Dec '25 Dec '24
Dividend Per Share
0.0660.0570.056
Dividend Per Share Growth
0%1.79%-
Dividend Yield
1.26%0.85%0.92%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.9512.0510.98---
P/FCF Ratio
-8.1219.10---
PS Ratio
0.841.281.11---